Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
14 April 2024
|
|
m 17:29 | Non-small cell lung cancer, nonsquamous 2 changes history +78 [Jwarner (2×)] | |||
| m |
|
17:29 (cur | prev) +45 Jwarner talk contribs →Maintenance after first-line therapy | |||
| m |
|
17:28 (cur | prev) +33 Jwarner talk contribs →Consolidation after definitive therapy for inoperable disease | |||
12 April 2024
|
|
00:18 | Non-small cell lung cancer, ALK-positive 5 changes history +8,545 [Jwarner (5×)] | |||
|
|
00:18 (cur | prev) +3,422 Jwarner talk contribs →Carboplatin & Pemetrexed {{#subobject:b94ckc|Regimen=1}} | ||||
|
|
00:16 (cur | prev) +3,428 Jwarner talk contribs →Cisplatin & Pemetrexed {{#subobject:b9uc2c|Regimen=1}} | ||||
| m |
|
00:13 (cur | prev) 0 Jwarner talk contribs →Regimen variant #2, 750 mg/day fasting {{#subobject:47c6e4|Variant=1}} | |||
| m |
|
00:13 (cur | prev) +4 Jwarner talk contribs | |||
| m |
|
00:12 (cur | prev) +1,691 Jwarner talk contribs →Carboplatin & Pemetrexed {{#subobject:b94ckc|Regimen=1}} | |||
11 April 2024
|
|
17:47 | Non-small cell lung cancer, ALK-positive 4 changes history +3,724 [Jwarner (4×)] | |||
| m |
|
17:47 (cur | prev) +6 Jwarner talk contribs | |||
|
|
17:47 (cur | prev) +1,691 Jwarner talk contribs →Alectinib monotherapy {{#subobject:bbc3cc|Regimen=1}} | ||||
| m |
|
15:48 (cur | prev) +6 Jwarner talk contribs | |||
|
|
15:48 (cur | prev) +2,021 Jwarner talk contribs →Advanced or metastatic disease, ALK inhibitor-naive | ||||